Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hainan Rizhontian Pharmaceutical is a comprehensive pharmaceutical enterprise based in Haikou, China, focused on the research, development, and large-scale production of finished drug products. Established in 1993, the company operates modern GMP-certified facilities producing a variety of dosage forms, including tablets, capsules, and granules. Its product portfolio primarily targets anti-infective, cardiovascular, and gastrointestinal therapeutic areas, with a strong emphasis on high-quality generic medications. Rizhontian Pharmaceutical serves both the domestic Chinese market and international clients through its integrated manufacturing and distribution network. The company is recognized as a key industrial player in the Hainan Free Trade Port region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hainan Rizhontian Pharmaceutical.